Odistad 120

Orlistat inhibits dietary fat absorption by inhibiting lipases. The inactivated enzymes are thus unavailable to hydrolyze dietary fat into absorbable forms.

Pack sizeBox of 42 capsules
Shelf-life24 months
CompositionOrlistat (as orlistat pellets 50%)
Dosage forms and strengthsHard gelatin capsule: 120 mg
Product code :



Conjunction with a mildly hypocaloric diet for the treatment of obese patients (BMI ≥ 30 kg/m2) or overweight patients (BMI ≥ 28 kg/m2) with associated risk factors (hypertension, diabetes mellitus, hyperlipidemia).


Management of obesity and weight regain in adults and adolescents 12 years of age and older: 120 mg three times daily with each main meal containing fat. Dosage exceeding three times daily does not provide additional benefit.

Safety and efficacy in children younger than 18 years of age have not been established.

No dosage adjustment is necessary in elderly and in individuals with hepatic and/ or renal impairment.


Take Odistad 120 with water immediately before, during or up to 1 hour after each main meal. If a meal is missed or contains no fat, the dose of Odistad 120 should be omitted.

Known hypersensitive to any of the active substance or excipients.

Chronic malabsorption syndrome or cholestasis.

Concurrent treatment with ciclosporin.

Pregnancy and breast-feeding.

Concurrent treatment with warfarin or other anticoagulants.

Common: Gastrointestinal disturbances, including faecal urgency and incontinence, flatulence, and fatty stools or discharge (should limit fat in meals).

Rare: Headache, anxiety, fatigue, rectal bleeding, and menstrual irregularities.

Orlistat should be given with caution to patients with a history of hyperoxaluria or calcium oxalate nephrolithiasis.

Adjustments to dosage of hypoglycaemics may be necessary in patients with type II diabetes because of improved metabolic control after weight loss.

Supplements of fat-soluble vitamins during long-term therapy: take them at least 2 hours before or after an orlistat dose or at bedtime.

Hormonal contraceptive failures in the event of severe diarrhoea with orlistat, patients are advised to use an additional contraceptive method.

Orlistat is not recommended for use during pregnancy and breastfeeding.